Cardinal Capital Management Has $1.07 Million Position in National Research Co. (NASDAQ:NRC)

Cardinal Capital Management boosted its holdings in shares of National Research Co. (NASDAQ:NRC) by 63.3% in the first quarter, according to its most recent filing with the SEC. The firm owned 26,988 shares of the company’s stock after acquiring an additional 10,463 shares during the period. Cardinal Capital Management’s holdings in National Research were worth $1,072,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Gladius Capital Management LP boosted its position in shares of National Research by 59.8% during the fourth quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock worth $52,000 after purchasing an additional 496 shares in the last quarter. Swiss National Bank increased its stake in shares of National Research by 1.6% during the 3rd quarter. Swiss National Bank now owns 32,500 shares of the company’s stock worth $1,442,000 after purchasing an additional 500 shares during the last quarter. Portside Wealth Group LLC increased its stake in shares of National Research by 11.9% during the 4th quarter. Portside Wealth Group LLC now owns 5,238 shares of the company’s stock worth $207,000 after purchasing an additional 555 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in National Research by 184.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock valued at $126,000 after buying an additional 2,061 shares during the last quarter. Finally, BNP Paribas Financial Markets grew its stake in National Research by 22.3% in the 4th quarter. BNP Paribas Financial Markets now owns 11,479 shares of the company’s stock valued at $454,000 after buying an additional 2,095 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Stock Performance

NASDAQ NRC opened at $22.99 on Friday. The company has a quick ratio of 0.41, a current ratio of 0.41 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $549.00 million, a P/E ratio of 18.54 and a beta of 0.56. National Research Co. has a 12-month low of $22.75 and a 12-month high of $47.25. The firm has a 50-day moving average price of $29.50 and a two-hundred day moving average price of $35.73.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter. National Research had a net margin of 20.60% and a return on equity of 54.83%. The company had revenue of $35.31 million during the quarter.

National Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Friday, June 28th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.09%. The ex-dividend date is Friday, June 28th. National Research’s payout ratio is 38.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.